Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (800)	8/25/1999 11:27:00 PM
From: Mike M	Read Replies (1) \| Respond to of 5582

You might want to call Gary and ask him directly;... I am sure he was being conservative...but I did ask him directly....His response was words to the effect that "you didn't hear from me that I am expecting the NEJM to publish".... Of course it is true that he wants the second study in order to solidify claims for labeling. I merely "speculated" that perhaps another goal was to add bite to the first study and might enhance likelihood of NEJM publication. It was after that conversation that I was not surprised when June and July passed without event. That Brown would suggest these results might not go to NEJM throws a bit of cold water on my logic. That it might go to JAMA, however, improves the odds that someone will publish. Thanks for your comments.